Cancer Colorectal Clinical Trial
Official title:
Increasing Access to Colorectal Cancer Screening Among Immigrants
The goal of this randomized trial is to test the effect of a reminder telephone call in the official native language in the country where the invitee is born, in addition to the reminder letter in Norwegian on participation in the National Colorectal Cancer Screening Program in Pakistani and Somalian immigrants, compared to the reminder letter in Norwegian only. The main question it aims to answer is: •Does a reminder telephone call in the language of origin increase participation in colorectal cancer screening in Pakistani and Somalian immigrants in Norway? Participants in this trial are individuals with Pakistan or Somalia as their country of birth invited to the National Colorectal Cancer Screening Program, who have not participated by mailing a faecal sample to the screening laboratory. In the intervention group, the participants will be called in the official language in their country of origin, to inform about colorectal cancer screening, in addition to the reminder letter in Norwegian language sent to all non-participants. Participants in the comparison group will only be sent the reminder letter in Norwegian language. The researchers will compare differences in the participation rate in the National Colorectal Cancer Screening Program between the intervention and comparison groups.
Status | Not yet recruiting |
Enrollment | 600 |
Est. completion date | March 30, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Pakistan or Somalia registered as country of birth - Invited to the first round of faecal screening test in the National Colorectal Cancer Screening Program in Norway - Reminder letter sent after no received faecal sample in the screening laboratory within six weeks from mailing of the faecal screening sample kit from the screening organizers Exclusion Criteria: - Individuals whose mailed reminder letter is returned to sender - Individuals whose faecal screening sample is registered in the screening laboratory 1) on the same day or the day after the reminder letter is sent out (applies to those who receive a digital reminder), or 2) on the same day or up to three days after the reminder letter is sent out (applies to those who receive a mailed reminder letter) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Norwegian Institute of Public Health |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | First round screening participation | Participation rate in the first colorectal cancer screening round. For each randomized individual, it is measured whether or not the faecal sample is sent to the screening laboratory by the participant in the first round of screening (yes/no). | within 12 weeks (84 days) from mailing of the screening reminder letter | |
Secondary | Overall screening participation | Participation rate in all five rounds of colorectal cancer screening. For each randomized individual, it is measured to which degree faecal samples are sent to the screening laboratory by the participant (yes, in all five rounds of screening/yes, in 1-4 rounds of screening/no). | within six months from mailing of the last screening round invitation (of up to five rounds) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05536089 -
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
|
||
Active, not recruiting |
NCT04392479 -
TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.
|
Phase 3 | |
Not yet recruiting |
NCT05577143 -
Blood Screening for Adult Colorectal Cancer
|
||
Active, not recruiting |
NCT05585866 -
Propofol and Sevoflurane Anesthesia in Colorectal Cancer Surgery: Incidence of Acute Kidney Injury
|
||
Recruiting |
NCT05573022 -
Impact of a Patient Decision Aid Intervention
|
N/A | |
Completed |
NCT02931825 -
Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System
|
N/A | |
Recruiting |
NCT03301493 -
Genomic Testing and Resulting Medical Decisions
|
||
Not yet recruiting |
NCT05791747 -
Representations, Beliefs and Attitudes Towards Hypnosis in Patients Followed for Colorectal Cancer
|
||
Recruiting |
NCT05830097 -
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04258813 -
Onco-primary Care Networking to Support TEAM-based Care
|
N/A | |
Active, not recruiting |
NCT05939440 -
Interventions to Decrease Financial Toxicity
|
N/A | |
Completed |
NCT04548765 -
Evaluation of Letters Promoting Colorectal Cancer Testing
|
N/A | |
Recruiting |
NCT04189055 -
Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.
|
Phase 2 | |
Recruiting |
NCT04592003 -
French Colorectal ESD Cohort in Experts Centers
|
||
Withdrawn |
NCT04345952 -
Calm for Cancer Patients Receiving Chemotherapy
|
N/A | |
Completed |
NCT04280393 -
Effectiveness and Safety of the Colonoscopy Assisted by Endocuff vs. Standard in the Colorectal Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06231576 -
Digital Home-Based Prehabilitation Before Surgery
|
N/A | |
Recruiting |
NCT04874883 -
Effect of the Use of Symbiotics in Patients With Colon Cancer
|
Phase 4 | |
Completed |
NCT04074460 -
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
|
Phase 4 | |
Not yet recruiting |
NCT06191185 -
IMProving Adherence to Colonoscopy Through Teams and Technology
|
N/A |